Objectives To evaluate whether type 2 diabetes mellitus (T2DM) presence and severity are associated with differences in global and domain-specific cognitive function among US adults, using ...

A study published in the Journal of Veterinary Pharmacology and Therapeutics on Feb. 7, 2026, has quantified the amount of ...

A new report finds women lost an average of 10.9% body weight vs. 6.8% for men on GLP-1 drugs. Dr. Todd Ellerin of South Shore Health explains possible reasons and next steps for men.

Thinking about GLP-1 meds? A Hy-Vee dietitian explains how to eat to protect muscle, energy and digestion when your appetite drops.

Meta-analysis of 64 clinical trials 'should give clinicians and their patients more confidence,' say Hopkins researchers ...

Among six trials that analyzed outcomes for nearly 20,000 participants by sex, women lost an average of 10.88% (95% CI -14.76 to -7) of their baseline body weight on a GLP-1 agent, while men lost 6.8% ...

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and ...

Scientists are taking a closer look at the pill forms of Wegovy and Ozempic. In an animal study, the ingredient SNAC, which helps semaglutide survive the stomach and enter the bloodstream, was ...

GLP-1s were first approved in 2005 for the treatment of Type 2 diabetes. Since then, more versions of the medication have hit the market, becoming more accessible to patients and used for a wider ...

GLP-1 medications are everywhere, but what happens when appetite suppression meets a culture obsessed with thinness?

But what’s the real story behind this herb, and when is the best time to take ashwagandha to reap the most health benefits?